Joe Biden can’t score a win – unless he has the help of his party to rig a national election, of course. Considering this man can’t string together a coherent sentence, does anybody honestly believe he received more votes than President Trump last November?
Let’s all hope and pray that audit findings are strong enough to decertify the 2020 election and put the rightful POTUS back in office. America needs Trump, whether some people understand it or not.
Here’s the latest blow to Joe and co., regarding COVID-19.
LOOK:
BREAKING: FDA panel votes against approving a Pfizer booster dose for COVID-19, weeks after President Joe Biden promised all Americans would be able to get boosters beginning in late September.
— Dylan Housman (@Dylan_Housman) September 17, 2021
The vote wasn't close. I'll have to go back to double-check the count, but it was at least a 2-1 or 3-1 ratio against.
— Dylan Housman (@Dylan_Housman) September 17, 2021
The panel still may move forward and approve booster doses for elderly Americans only, we will see.
— Dylan Housman (@Dylan_Housman) September 17, 2021
Several members of the panel essentially expressed the idea that yes the data is good for boosters for the elderly, but we can't extrapolate that data all the way down to people 16 and older. The failed vote would've approved the shot for everyone 16 or older.
— Dylan Housman (@Dylan_Housman) September 17, 2021
The final vote was 16-3 against approval. We will see what the vote on senior approval is, assuming that's where they go next.
— Dylan Housman (@Dylan_Housman) September 17, 2021
16-2 after it was determined one vote was made in error. An 8-1 ratio sends Pfizer's pitch down in flames.
— Dylan Housman (@Dylan_Housman) September 17, 2021
Read more here, including about the two FDA vaccine officials who are resigning this year after reportedly growing frustrated with the Biden administration's rush to push boosters: https://t.co/kZKynPbKVn
— Dylan Housman (@Dylan_Housman) September 17, 2021
NOW: the panel is moving to vote on whether the known and potential benefits of a 6-month booster dose outweigh the known and potential risks for those 65 and older or individuals at high risk of severe COVID-19.
— Dylan Housman (@Dylan_Housman) September 17, 2021
UNANIMOUS 18-0 vote that YES, the booster doses should be approved for the elderly and at-risk.
— Dylan Housman (@Dylan_Housman) September 17, 2021
VIDEO:
"*" indicates required fields
